Liminatus Pharma, Inc. (LIMN)
Nasdaq: LIMN · Biological Products, (No Diagnostic Substances) · Cerritos, CA · filing with the SEC since 2023
Who owns Liminatus Pharma, Inc.
As filed with the SECHolders of 5% or more
7
Iris Acquisition Holdings LLC holds 26.5% of Common Stock, as its SCHEDULE 13D filed May 8, 2025 says.
Directors and officers
3
report now, of 10 people on the record since 2025. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Iris Acquisition Holdings LLC
SCHEDULE 13D · filed May 8, 2025 · Common Stock
KH Feelux Co., Ltd
SCHEDULE 13G · filed Jun 27, 2025 · Common Stock, $0.0001 par value per share
Valetudo Therapeutics LLC
SCHEDULE 13D/A · filed Jul 14, 2026 · Common Stock, par value $0.0001 per share · 23.7% in May 7, 2025
Ewon Comfortech Co., Ltd.
SCHEDULE 13G/A · filed Jul 6, 2026 · Common Stock , par value $0.0001 per share · 5.8% in Jun 26, 2025
Red Peony Association 1st
SCHEDULE 13G · filed Jun 26, 2025 · Common Stock , par value $0.0001 per share
Nongae Apple Association 1st
SCHEDULE 13G · filed Jun 26, 2025 · Common Stock , par value $0.0001 per share
Samda Biolab Co., Ltd.
SCHEDULE 13G · filed Jul 22, 2026 · Common Stock , par value $0.0001 per share
Mitchell P. Kopin
SCHEDULE 13G · filed Feb 20, 2026 · Common Stock, par value $ 0.0001 per share · reported falling below 5%
What LIMN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Iris Acquisition Corp
An entity · legal entity · owns, named in the 10-K filed Mar 31, 2026
Liminatus and Iris
A company bought · acquisition · owns, named in the 10-K filed Mar 31, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.